OrbiMed
PEHQ: New York, United States · Founded 1989
OrbiMed is a leading healthcare-dedicated investment firm, with approximately $17 billion in assets under management. The firm invests globally across the healthcare industry, from venture capital to large buyouts.
Investment Focus
Industries
HealthcareBiotechnologyLife SciencesMedical Devices
Stage
GrowthBuyoutLate Stage
Region
North America
AUM
$17B
Portfolio Companies
C
Cardiovascular Systems
Growth · 2015
M
Moderna
ExitGrowth · 2013
J
Jazz Pharmaceuticals
ExitBuyout · 2012
Key Contacts
Contact information available with Pro plan.
Full contact details available with Pro plan
Quick Stats
Founded1989
AUM$17B
Fund Size$17B
Investments350
Exits85
ESG FocusNo